rHEALTH Nanostrips, Vitals Device, and Fluidics Module to Receive U.S. Patent Protection. Expands patent protection for diagnose yourself, anywhere technology CAMBRIDGE, Mass., May 21, 2019 -- DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, today announced that three separate aspects of its technology platform has received a Notice of Allowance and two Issue Notifications from the...Read more
Recent Posts by DMI
rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes This patent enables rHEALTH’s unique technology to measure many analytes in a given small volume sample at home or in the clinic CAMBRIDGE, Mass., January 23, 2019 /PRWeb/ -- rHEALTH LLC, an innovative digital health solutions company, announced today that...Read more
Dr. Chan will present the rHEALTH technology at NASA's Human Research Program (HRP) Investigator's Workshop (IWS). The rHEALTH blood sensor is the subject of a NASA CCRPP contract to deliver comprehensive blood analysis capabilities for long-duration space travel. It is utilized in conjunction with the SKYE Sensor which enables comprehensive bioanalytical vitals information...Read more
CAMBRIDGE, Mass., Oct. 4, 2018 /PRNewswire-iReach/ -- rHEALTH LLC, an innovative digital health solutions company, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/645,388, entitled “Sample Consumable and Loader” filed by its affiliate company, DNA Medicine Institute (DMI). This...Read more
Dr. Chan will be presenting a talk titled, "XPRIZE Tricorders and Point-of-Consumer Blood Diagnostics: Where are we now?" at the Athena Society, Corfu, Greece on September 8, 2018. http://athenasociety.org...Read more
Recent Comments by DMI
No comments by DMI yet.